» Articles » PMID: 34278302

Clinicopathologic and Immunohistochemical Characteristics of Solitary Fibrous Tumor and Its Mimics: A Single-Center Experience

Overview
Journal Clin Pathol
Publisher Sage Publications
Date 2021 Jul 19
PMID 34278302
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Solitary fibrous tumor (SFT) is a fibroblastic tumor that has been originally reported as a pleural tumor but now has been defined as a tumor that can be seen everywhere in the human body. Histopathologically, many of the fibroblastic tumors can mimic SFT, and immunohistochemistry is necessary for differential diagnosis. Several markers have been used, and recently, STAT6 has been introduced as a diagnostic marker. No research study has been reported from Iran.

Objectives: In this report, we are trying to introduce our experience about the clinicopathologic findings of 35 cases of SFT during the last 10 years from our center with an emphasis on the diagnostic role of STAT6 in this tumor.

Patients And Methods: During the last 10 years, we confirmed the diagnosis of 35 cases of SFT in the pathology archives of Shiraz University of Medical Sciences. These 35 cases were considered as cases. All the clinicopathologic findings were also extracted from the clinical charts of the patients. To evaluate the diagnostic role of STAT6, another 35 cases of spindle cell tumors were also extracted from the pathology archives as mimickers of SFT. STAT6 was stained in all of the 70 cases and controls.

Results And Discussion: Our experience showed that SFT is more common in middle-aged men with a wide age range, although it is very rare in children. It can be present in every location with a wide size range from less than 1 cm to more than 15 cm. The presence of abnormal staghorn vessels is one of the main diagnostic histopathologic characteristics. STAT6 showed a sensitivity and specificity of 91% and 86% in the diagnosis of SFT. Other markers such as CD99, CD34, and BCL2 have also been considered useful in the differential diagnosis of this tumor, although the diagnostic accuracy seems to be lower than STAT6. High mitosis, presence of necrosis, and atypia are important criteria for predicting malignant and aggressive behavior in SFT. Among 35 cases in our study, 17% showed malignant behavior as recurrent or metastatic tumors.

Conclusion: Solitary fibrous tumor is a common soft tissue tumor that can be seen everywhere and needs careful histopathologic and immunohistochemical evaluation for the correct diagnosis and prediction of aggressive or benign behavior.

Citing Articles

Exploring Solitary Fibrous Tumors at a Tertiary Cancer Center: Clinicopathological and Immunomorphologic Profile.

Chowdhury Z, Mishrikotkar S, Nehra P, Patne S, Tripathi M Cureus. 2024; 16(3):e56899.

PMID: 38659562 PMC: 11042756. DOI: 10.7759/cureus.56899.


Solitary Fibrous Tumors of the Head and Neck: A Single-Institution Study of 52 Patients.

Chung H, Tam K, Han A, Obeidin F, Nakasaki M, Chhetri D OTO Open. 2022; 6(3):2473974X221098709.

PMID: 35845143 PMC: 9280824. DOI: 10.1177/2473974X221098709.


F-FDG PET/CT characteristics of solitary fibrous tumour of the pleura: single institution experience.

Zhao L, Wang H, Shi J Ann Nucl Med. 2022; 36(5):429-438.

PMID: 35137364 DOI: 10.1007/s12149-022-01723-x.

References
1.
Fukunaga M, Naganuma H, Nikaido T, Harada T, Ushigome S . Extrapleural solitary fibrous tumor: a report of seven cases. Mod Pathol. 1997; 10(5):443-50. View

2.
Dong S, Wang N, Yang C, Zhang G, Liang W, Zhao J . Giant Cell-Rich Solitary Fibrous Tumor in the Nasopharynx: Case Report and Literature Review. Onco Targets Ther. 2020; 13:6819-6826. PMC: 7367732. DOI: 10.2147/OTT.S252696. View

3.
Yoshida A, Tsuta K, Ohno M, Yoshida M, Narita Y, Kawai A . STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol. 2014; 38(4):552-9. DOI: 10.1097/PAS.0000000000000137. View

4.
Schweizer L, Koelsche C, Sahm F, Piro R, Capper D, Reuss D . Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol. 2013; 125(5):651-8. DOI: 10.1007/s00401-013-1117-6. View

5.
Robinson D, Wu Y, Kalyana-Sundaram S, Cao X, Lonigro R, Sung Y . Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet. 2013; 45(2):180-5. PMC: 3654808. DOI: 10.1038/ng.2509. View